Barclays lowered the firm’s price target on Bath & Body Works to $28 from $32 and keeps an Equal Weight rating on the shares after meeting with management. The firm believes Bath & Body’s “focus on fewer” strategy and brand strength will drive a business inflection in the second half of 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target lowered to $28.50 from $32 at Jefferies
- Bath & Body Works downgraded to Neutral from Overweight at JPMorgan
- Trump Weekly: President threatens new tariffs, announces TikTok deal
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
- Trump plans to impose 50% tariff on kitchen cabinets, bathroom vanities